Phytochemical investigation identified four new coumarins with strong CYP1 inhibitory activity, suggesting potential antitumor uses.
Phytochemical investigation of the leaves and stems of Calophyllum membranaceum Gardn. et Champ. led to the isolation of four new coumarins, calomembolides G–J ( 1 – 4 ), along with three known coumarins, including calanolide E 2 ( 5 ), calanolide E 1 ( 6 ), and calopolyanolide B ( 7 ). Their structures were determined on the basis of extensive spectroscopic and spectrometric data analyses, and computational studies. Seven coumarins were tested for inhibitory effects on CYP family 1 enzymes. Compounds 4 and 6 exhibited significant inhibitory activity and selectivity toward CYP1B1 and CYP1A1 enzymes, respectively, showing inhibition rates of 79.11% ± 12.95% and 29.95% ± 8.09%. These compounds can provide a new material basis for the development of CYP1‐targeted antitumor drugs.
No takes yet. Share an insight, caveat, or question.
Cao et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: